{"entity":{"type":"insider","cik":"0001426004","url":"/insider/0001426004","json_url":"/insider/0001426004.json","name":"Pearson J. Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2008-06-03","last":"2015-11-09","span_basis":"filed_date"},"name_variants":[{"name":"Pearson J. Michael","source":"filing","n_filings":10,"first_seen":"2008-06-03","last_seen":"2015-11-09"}],"transactions":[{"id":8807099,"accession":"0000885590-15-000078","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-15-000078","line_url":"/filing/0000885590-15-000078","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297399.0,"shares_display":"1,297,399","price_per_share":78.4846989091251,"price_display":"78.48","price_state":"stated","total_value":101825969.88,"total_display":"101,825,969.88","total_whole":"101,825,970","shares_owned_after":1864664.0,"shares_owned_after_display":"1,864,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-05","filed_date":"2015-11-09","scope":"insider","n_lines":3},{"id":4380131,"accession":"0000885590-13-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000101","line_url":"/filing/0000885590-13-000101#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":184247.0,"shares_display":"184,247","price_per_share":81.41,"price_display":"81.41","price_state":"stated","total_value":14999548.27,"total_display":"14,999,548.27","total_whole":"14,999,548","shares_owned_after":4025498.0,"shares_owned_after_display":"4,025,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-14","filed_date":"2013-12-17","scope":"insider"},{"id":9117253,"accession":"0000885590-11-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000057","line_url":"/filing/0000885590-11-000057#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155642.0,"shares_display":"155,642","price_per_share":38.6192,"price_display":"38.62","price_state":"stated","total_value":6010769.5264,"total_display":"6,010,769.53","total_whole":"6,010,770","shares_owned_after":5570503.0,"shares_owned_after_display":"5,570,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-15","scope":"insider"},{"id":5914932,"accession":"0001209499-09-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-09-000014","line_url":"/filing/0001209499-09-000014#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":18.51,"price_display":"18.51","price_state":"stated","total_value":129570.0,"total_display":"129,570.00","total_whole":"129,570","shares_owned_after":1259716.0,"shares_owned_after_display":"1,259,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-07","filed_date":"2009-05-08","scope":"insider"},{"id":3635748,"accession":"0001209499-08-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000081","line_url":"/filing/0001209499-08-000081#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51440.0,"shares_display":"51,440","price_per_share":16.2,"price_display":"16.20","price_state":"stated","total_value":833328.0,"total_display":"833,328.00","total_whole":"833,328","shares_owned_after":544859.0,"shares_owned_after_display":"544,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-03","filed_date":"2008-07-07","scope":"insider"},{"id":4039450,"accession":"0001209499-08-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000066","line_url":"/filing/0001209499-08-000066#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48761.0,"shares_display":"48,761","price_per_share":17.09,"price_display":"17.09","price_state":"stated","total_value":833325.49,"total_display":"833,325.49","total_whole":"833,325","shares_owned_after":493419.0,"shares_owned_after_display":"493,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-26","filed_date":"2008-06-27","scope":"insider"},{"id":3863511,"accession":"0001209499-08-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000061","line_url":"/filing/0001209499-08-000061#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48847.0,"shares_display":"48,847","price_per_share":17.06,"price_display":"17.06","price_state":"stated","total_value":833329.82,"total_display":"833,329.82","total_whole":"833,330","shares_owned_after":444658.0,"shares_owned_after_display":"444,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-20","scope":"insider"},{"id":3635745,"accession":"0001209499-08-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000057","line_url":"/filing/0001209499-08-000057#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49900.0,"shares_display":"49,900","price_per_share":16.7,"price_display":"16.70","price_state":"stated","total_value":833330.0,"total_display":"833,330.00","total_whole":"833,330","shares_owned_after":395811.0,"shares_owned_after_display":"395,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3276224,"accession":"0001209499-08-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000053","line_url":"/filing/0001209499-08-000053#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50505.0,"shares_display":"50,505","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":833332.5,"total_display":"833,332.50","total_whole":"833,333","shares_owned_after":345911.0,"shares_owned_after_display":"345,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-05","filed_date":"2008-06-09","scope":"insider"},{"id":3838053,"accession":"0001209499-08-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-08-000050","line_url":"/filing/0001209499-08-000050#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001426004","owner_name":"Pearson J. Michael","owner_display_name":"Pearson J. Michael","owner_url":"/insider/0001426004","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50906.0,"shares_display":"50,906","price_per_share":16.37,"price_display":"16.37","price_state":"stated","total_value":833331.22,"total_display":"833,331.22","total_whole":"833,331","shares_owned_after":295406.0,"shares_owned_after_display":"295,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-30","filed_date":"2008-06-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2011-08-15","last_seen":"2015-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000930184","name":"VALEANT PHARMACEUTICALS INTERNATIONAL","url":"/issuer/0000930184","role":"Director, Officer (CEO and Chairman of the Board)","n_filings":7,"first_seen":"2008-06-03","last_seen":"2009-05-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001426004","retrieved_at":"2026-08-22T14:55:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}